HSV-2 gC Antibodies

Santa Cruz Biotechnology features a diverse variety of HSV-2 gC monoclonal antibodies for research focused on understanding glycoprotein C in herpes simplex virus type 2. HSV-2 gC Antibodies are available for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Glycoprotein C plays a vital role in helping herpes simplex virus type 2 evade host immune responses, making it an important target for therapeutic intervention and vaccine development. Through binding to complement component C3b, HSV-2 gC prevents opsonization and phagocytosis, which enables viral survival and propagation. Research into HSV-2 gC mechanisms continues to reveal new aspects of viral pathogenesis. Understanding these mechanisms is essential for developing effective treatments against herpes infections. Investigating the molecular interactions of HSV-2 gC provides valuable insights into viral immune evasion strategies. Current research utilizing HSV-2 gC monoclonal antibodies helps advance scientific understanding of viral infections and immune responses. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in their mission to develop new therapeutic strategies against viral diseases.